T40.7X2A Poisoning by cannabis (derivatives), intentional self-harm, initial encounter

Name of the Condition

• Common name: Intentional self-harm by cannabis (derivatives) poisoning
• Medical terms: Deliberate cannabis (derivatives) toxicity, initial encounter

Summary

This ICD code describes intentional self-harm from cannabis (derivatives) poisoning during the initial encounter. It applies to cases where exposure to cannabis causes harm due to deliberate intent, typically involving self-inflicted overdose or misuse. The code is specific to the initial phase of care for this condition.

Causes

Intentional self-harm may result from deliberate ingestion or inhalation of cannabis products with the intent to cause harm. This can include overdose of high-potency formulations, misuse of edibles, or intentional exposure to concentrated forms. It may occur in the context of mental health crises or substance use disorders.

Risk Factors

• History of suicidal ideation or attempts
• Co-occurring mental health conditions (e.g., depression, anxiety)
• Substance use disorders involving cannabis or other drugs
• Access to high-potency cannabis products
• Social or environmental stressors contributing to self-harm behaviors

Symptoms

• Altered mental status (e.g., confusion, disorientation)
• Severe anxiety, panic, or paranoia
• Nausea, vomiting, or abdominal pain
• Tachycardia or palpitations
• Drowsiness, lethargy, or loss of consciousness
• Respiratory depression (with high doses)
• Hallucinations or psychosis (with potent products)

Diagnosis

Diagnosis involves clinical assessment of symptoms, patient history (including intent), and toxicology screening for cannabis. Documentation of self-harm intent is critical. Physical exam may reveal signs of overdose, and lab tests (e.g., urine or blood) can confirm cannabis exposure. Differential diagnosis includes other substance poisonings or medical conditions.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying intent. This may include airway support, cardiovascular monitoring, and symptomatic care (e.g., antiemetics, sedation). Psychiatric evaluation and crisis intervention are essential. In severe cases, intensive care or detoxification may be required.

Prognosis and Follow-Up

Prognosis depends on the dose, potency, and timely intervention. Most cases resolve with supportive care, but severe toxicity can lead to complications. Follow-up includes psychiatric assessment, safety planning, and referral to mental health services. Ongoing monitoring for recurrence or substance use is recommended.

Complications

• Respiratory failure or arrest
• Cardiovascular instability (e.g., arrhythmias)
• Seizures or coma
• Long-term psychiatric effects (e.g., psychosis)
• Renal or hepatic injury (rare with isolated cannabis)

Lifestyle & Prevention

• Secure storage of cannabis products to prevent access
• Education on safe use and potency awareness
• Mental health support for at-risk individuals
• Avoidance of high-potency products in vulnerable populations
• Regular screening for substance use or suicidal ideation

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., loss of consciousness, respiratory distress) or suspected self-harm. Prompt evaluation is critical for stabilization and intervention. Contact emergency services or a healthcare provider if intent or risk is unclear.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (initial) clearly. Include details on substance exposure, clinical findings, and psychiatric evaluation. Ensure coding aligns with the ICD-10-CM guidelines for poisoning and self-inflicted injury.